Image from Google Jackets

Syntheses and potential anti-prostate cancer activities of ionone-based chalcones

Tipo de material: TextoTextoSeries ; Bioorganic & Medicinal Chemistry Letters, 19(4), p.1183-1186, 2009Trabajos contenidos:
  • Zhou, J
  • Geng, G
  • Batist, G
  • Hui Wua, J
Tema(s): Recursos en línea: Resumen: We report the SAR studies of 43 ionone-based chalcones that demonstrate substantial in vitro anti-proliferative activities in LNCaP, MDA-PCa-2b, 22Rv1, C4-2B and PC-3 prostate cancer cell lines. Compound 25 with an IC50 value of 0.74 lM in LNCaP cells potently antagonizes DHT-induced transactivation of the wild type and the clinically relevant T877A, W741C and H874Y mutated androgen receptors, representing a novel chalcone as pan-antagonist of androgen receptor.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Collection Call number Status Date due Barcode
Documentos solicitados Documentos solicitados CICY Documento préstamo interbibliotecario Ref1 B-11230 (Browse shelf(Opens below)) Available

We report the SAR studies of 43 ionone-based chalcones that demonstrate substantial in vitro anti-proliferative activities in LNCaP, MDA-PCa-2b, 22Rv1, C4-2B and PC-3 prostate cancer cell lines. Compound 25 with an IC50 value of 0.74 lM in LNCaP cells potently antagonizes DHT-induced transactivation of the wild type and the clinically relevant T877A, W741C and H874Y mutated androgen receptors, representing a novel chalcone as pan-antagonist of androgen receptor.

There are no comments on this title.

to post a comment.